Jeremy R. Paull

Jeremy R. Paull

General Counsel bei STARPHARMA HOLDINGS LIMITED

Vermögen: 3 337 $ am 30.04.2024

Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Jeremy R. Paull

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 26
20
Private Company Miscellaneous Commercial Services 20

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jeremy R. Paull

UnternehmenSektorVerknüpfte PersonenHauptposition
CSL LIMITED Biotechnology

Peter Turvey

Zita Peach

Peter Bradley

Tony Eglezos

General Counsel

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED Pharmaceuticals: Major

Russell Basser

Director/Board Member

VISION EYE INSTITUTE LTD Medical/Nursing Services

Zita Peach

Director/Board Member

Melbourne Business School College/University

Jacinth Fairley

Malcolm McColl

Peter Bradley

Masters Business Admin

Masters Business Admin

Graduate Degree

PATRYS LIMITED Pharmaceuticals: Major

James Campbell

Chief Executive Officer

University of Pennsylvania College/University

Roman Salij

Undergraduate Degree

OPTHEA LIMITED Biotechnology

Lawrence Gozlan

Megan Baldwin

Clare Price

Director/Board Member

Founder

Corporate Officer/Principal

PRESCIENT THERAPEUTICS LIMITED Biotechnology

James Campbell

Director/Board Member

VIRALYTICS LTD. Biotechnology

Peter Turvey

Malcolm McColl

Director/Board Member

Chief Executive Officer

University of Adelaide College/University

Peter Colman

Meera Verma

Doctorate Degree

Doctorate Degree

College/University

John W. Raff

Jacinth Fairley

Chris Nave

Lawrence Gozlan

James Campbell

Darren James Kelly

Malcolm McColl

Megan Baldwin

Ann Hamer

Russell Basser

Zita Peach

Lynda Cheng

Tony Eglezos

Debbie Beadle

Helen Fisher

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Graduate Degree

College/University

Jeff Davies

Robert Thomas

Doctorate Degree

Undergraduate Degree

TRIVARX LIMITED Packaged Software

James Campbell

Director/Board Member

Pharmaceuticals: Major

David J. Owen

Nigel J. Baade

Corporate Officer/Principal

Director of Finance/CFO

College/University

Roman Salij

Masters Business Admin

The University of Sydney College/University

David McIntyre

David Fisher

Undergraduate Degree

Doctorate Degree

College/University

Robert Thomas

Sam di Giacomo

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Russell Basser

Chief Tech/Sci/R&D Officer

University of Technology Sydney College/University

David McIntyre

Tony Eglezos

Graduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Peter Turvey

Nigel J. Baade

Darren James Kelly

Megan Baldwin

Zita Peach

Lynda Cheng

Debbie Beadle

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

David Fisher

Stephen Thompson

Chris Nave

Private Equity Investor

Private Equity Investor

Chief Executive Officer

Pharmaceuticals: Major

Chris Nave

James Campbell

Director/Board Member

Director/Board Member

HEARTWARE INTERNATIONAL INC Medical Specialties

Robert Thomas

David McIntyre

Chairman

Director of Finance/CFO

BioMelbourne Network

John W. Raff

Chris Nave

Nigel J. Baade

Darren James Kelly

Zita Peach

Debbie Beadle

Chairman

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

Chris Nave

Darren James Kelly

Ann Hamer

Chairman

Chief Executive Officer

Chief Operating Officer

Roche Group Pty Ltd.

Megan Baldwin

Corporate Officer/Principal

Biotechnology

Peter James Jenkins

Robert Thomas

Director/Board Member

Chairman

Pargenex Pty Ltd.

James Campbell

Director/Board Member

SIENNA CANCER DIAGNOSTICS LIMITED Biotechnology

Ross Dobinson

Helen Fisher

Director/Board Member

Director/Board Member

Medical Specialties

David Fisher

Chris Nave

Director/Board Member

Director/Board Member

INVION LIMITED Pharmaceuticals: Major

James Campbell

Director/Board Member

Medical Specialties

Stephen Thompson

Dean Moss

Director/Board Member

Director/Board Member

Medical/Nursing Services

Zita Peach

Chief Executive Officer

Medical Distributors

James Campbell

Founder

Opthea Pty Ltd.

Megan Baldwin

Chief Executive Officer

Pharmaceuticals: Major

Dean Moss

Chris Nave

Director/Board Member

Director/Board Member

Biotechnology

Chris Nave

Darren James Kelly

Chairman

Founder

CSL Ltd. (United States)

Russell Basser

Chief Tech/Sci/R&D Officer

CLARITY PHARMACEUTICALS LTD Medical Specialties

Robert Thomas

Cheryl Maley

Director/Board Member

Director/Board Member

Biotechnology

Chris Nave

Darren James Kelly

Director/Board Member

Chief Executive Officer

INVEX THERAPEUTICS LTD Biotechnology

Megan Baldwin

Director/Board Member

Miscellaneous Commercial Services

Peter Turvey

Malcolm McColl

Chairman

Chief Executive Officer

Viralytics Ltd.

Malcolm McColl

Chief Executive Officer

Gemini Biotechnology

James Campbell

Corporate Officer/Principal

PARADIGM BIOPHARMACEUTICALS LIMITED Pharmaceuticals: Generic

Helen Fisher

Justin Cahill

Director/Board Member

Director of Finance/CFO

MEDLAB CLINICAL LIMITED Pharmaceuticals: Major

Sean Michael Hall

Cheryl Maley

Chief Executive Officer

Director/Board Member

Statistik

International

Australien 43
Vereinigte Staaten 8
Neuseeland 2

Sektoral

Health Technology 27
Consumer Services 10
Commercial Services 4
Health Services 3
Technology Services 2

Operativ

Director/Board Member 178
Corporate Officer/Principal 114
Chairman 50
Independent Dir/Board Member 42
Chief Executive Officer 40
  1. Börse
  2. Insiders
  3. Jeremy R. Paull
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT